Home › Funds › MPM BioImpact LLC › LQDA

MPM BioImpact LLC position in LQDA

LIQUIDIA CORPORATION · Health Care

MPM BioImpact LLC reported holding 1,386,174 shares of LQDA (LIQUIDIA CORPORATION) in its Q2 2026 13F filing — a position valued at US$110.5M, representing 6.74% of its reported portfolio and ranking #3 among its reported holdings. MPM BioImpact LLC has disclosed LQDA holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)1.39M sh
Reported value held$110.52M
Portfolio Weight6.74%
First reportedQ3 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How MPM BioImpact LLC's LQDA position evolved

MPM BioImpact LLC first disclosed a stake in LQDA in Q3 2025 at 200,000 shares (US$4.5M). The position peaked in Q2 2026 at 1,386,174 shares, worth US$110.5M. Across 4 filings, MPM BioImpact LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,386,174 shares valued at US$110.5M — a reduction of -18,984 shares quarter over quarter.. Notable position changes include a 600% increase in Q4 2025 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 200.00K $4.55M New
Q4 2025 1.40M $48.32M Add
Q1 2026 1.41M $53.03M Hold
Q2 2026 1.39M $110.52M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LQDA and 13F data

LQDA (LIQUIDIA CORPORATION) is a Health Care company. 73 other funds we track also report a position in LQDA — the largest reported positions include Farallon Capital Management (US$666.9M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$666.9M), Caligan Partners LP (US$647.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LQDA

All LQDA fund holders →

FAQ

How long has MPM BioImpact LLC held LQDA?

MPM BioImpact LLC has disclosed LQDA holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is MPM BioImpact LLC's current position in LQDA?

As of Q2 2026, MPM BioImpact LLC holds 1.39M shares of LQDA (LIQUIDIA CORPORATION), valued at $110.52M, representing 6.74% of its reported portfolio and ranking #3.

Has MPM BioImpact LLC been buying or selling LQDA?

In the latest 13F filing (Q2 2026), MPM BioImpact LLC reduced its position in LQDA. The position peaked in Q2 2026 at 1.39M shares.

Which other funds hold LQDA?

Other major institutional holders of LQDA include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., Caligan Partners LP, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.